Guides

Integrase inhibitors



bictegravir

19 February 2018. Related: ARVs, Integrase inhibitors

no separate formulation

Full details about bictegravir



Biktarvy: bictegravir/emtricitabine/TAF

26 June 2018. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Biktarvy is a pink/grey film-coated tablet (15 mm x 8 mm) with “GSI” on one side and “9883” on the other.

Full details about Biktarvy: bictegravir/emtricitabine/TAF



cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)

18 November 2021. Related: ARVs, Integrase inhibitors, NNRTIs

(not to scale)

Cabotegravir-LA and rilpivirine-LA are long acting injections given by intramuscular injections every two months.

Full details about cabotegravir LA + rilpivirine LA (Vocabria+Rekambys or Cabenuva)



dolutegravir

5 May 2015. Related: ARVs, Integrase inhibitors

dolutegravir

Dolutegravir 50 mg is a 9 mm diameter round yellow tablet.

Full details about dolutegravir



Dovato (dolutegravir + lamivudine)

3 February 2023. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Dovato is a white tablet embossed with “SV137”. (Source: aidsinfo.nih)

Full details about Dovato (dolutegravir + lamivudine)



elvitegravir

1 May 2018. Related: ARVs, Integrase inhibitors

elvitegravir - cropped - i-base combo guide

Single drug formulations of elvitegravir are no longer used. Instead, elvitegravir is included with other drugs in fixed dose combinations.

Full details about elvitegravir



Generic ARVs

2 November 2021. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs, Nukes, PIs

A generic drug is one that is manufactured by a different pharmaceutical company to the company that invented the medicine.

Full details about Generic ARVs



Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)

12 April 2016. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes, PK booster

genvoya 510 side

Full details about Genvoya: elvitegravir + cobicistat + emtricitabine + TAF (E/C/F/TAF)



Juluca (dolutegravir + rilpivirine)

12 May 2018. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs

Full details about Juluca (dolutegravir + rilpivirine)



raltegravir

3 January 2022. Related: ARVs, Integrase inhibitors

              isentress

Once-daily (600mg)          Twice-daily (400 mg)

Full details about raltegravir



Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)

4 January 2022. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Full details about Stribild (elvitegravir + cobicistat + emtricitabine (FTC) + tenofovir DF)



TLD (tenofovir disoproxil, lamivudine, dolutegravir)

24 December 2020. Related: ARVs, Fixed dose combinations, Integrase inhibitors, NNRTIs

Picture not included as there are many different versions.

Full details about TLD (tenofovir disoproxil, lamivudine, dolutegravir)



Triumeq (dolutegravir + abacavir + 3TC)

4 January 2022. Related: ARVs, Fixed dose combinations, Integrase inhibitors, Nukes

Triumeq image

Full details about Triumeq (dolutegravir + abacavir + 3TC)